{"id":79849,"date":"2024-11-18T10:02:47","date_gmt":"2024-11-18T10:02:47","guid":{"rendered":"https:\/\/www.cofb.org\/?p=79849"},"modified":"2024-11-18T10:13:09","modified_gmt":"2024-11-18T10:13:09","slug":"visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","title":{"rendered":"Visi\u00f3n multidisciplinar del paciente cardiorenal metab\u00f3lico, nuevo curso dirigido a farmac\u00e9uticos y farmac\u00e9uticas de atenci\u00f3n primaria y comunitarias"},"content":{"rendered":"

El pasado 25 de octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong>, con la colaboraci\u00f3n de la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC)<\/a>, <\/strong>organiz\u00f3 la formaci\u00f3n "Visi\u00f3n multidisciplinar del paciente cardiorenal metab\u00f3lico" <\/strong>con el patrocinio de Boehringer Ingelheim<\/a>. La formaci\u00f3n, dirigida a farmac\u00e9uticos y farmac\u00e9uticas de atenci\u00f3n primaria y comunitarias<\/strong>, fue impartida por profesionales sanitarios de diferentes especialidades<\/strong>.  <\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Los objetivos<\/strong> de la formaci\u00f3n fueron revisar las estrategias del sistema sanitario de atenci\u00f3n a la cronicidad<\/strong>, conocer la relaci\u00f3n entre el eje cardiorenal metab\u00f3lico con la insuficiencia renal<\/strong>, card\u00edaca <\/strong>y la diabetes mellitus<\/strong> y compartir experiencias pr\u00e1cticas reales<\/strong> llevadas a cabo en el territorio.<\/p>\n\n\n\n

Estrategias de atenci\u00f3n a la cronicidad<\/strong><\/h2>\n\n\n\n

La vocal de Atenci\u00f3n Primaria del COFB, Cristina Morales<\/strong>, introdujo la formaci\u00f3n que ofrece una "visi\u00f3n multidisciplinar sobre la importancia del manejo del paciente cardiorenal metab\u00f3lico"<\/strong>. Morales dio paso a la primera ponente de la jornada, la Dra.<\/strong> Nuria Molist,<\/strong> m\u00e9dica de la Unidad Geri\u00e1trica de Agudos de la Fundaci\u00f3n Hospital de la Santa Cruz de Vic y coordinadora del Grupo de Investigaci\u00f3n en Cronicidad de la Catalu\u00f1a Central, que habl\u00f3 sobre las estrategias de atenci\u00f3n a la cronicidad en global. <\/strong>"Los pacientes cardiorenales son pacientes con patolog\u00eda cr\u00f3nica y multimorbilidades", indic\u00f3 la Dra. En cuanto a la medicaci\u00f3n de las personas mayores, la m\u00e9dico asegur\u00f3 que "hasta m\u00e1s del 90% de personas de edad avanzada se pueden detectar discrepancias en su medicaci\u00f3n al cabo de 7 d\u00edas de alta de un hospital"<\/strong>.<\/p>\n\n\n\n

\"Cristina<\/a>
Cristina Morales y Nuria Molist introduciendo la formaci\u00f3n.<\/figcaption><\/figure>\n\n\n\n

En relaci\u00f3n con elatenci\u00f3n a las personas con cronicidad<\/strong>, la Dra. Molist explic\u00f3 que hay que pasar \u201cde una atenci\u00f3n centrada en la enfermedad<\/strong>, estandarizada y fragmentada, en una atenci\u00f3n centrada en la persona<\/strong>, individualizada, integrada y basada en la evidencia\u201d. Asimismo, tambi\u00e9n coment\u00f3 que para individualizar la atenci\u00f3n es necesario basarse "en la situaci\u00f3n basal, en el objetivo terap\u00e9utico individual y en la evidencia existente".<\/p>\n\n\n\n

Enfermedad renal cr\u00f3nica y su relaci\u00f3n con el eje cardiometab\u00f3lico<\/strong><\/h2>\n\n\n\n

A continuaci\u00f3n intervino el Dr. Jordi Bover<\/strong>, jefe del Servicio de Nefrolog\u00eda del Hospital Germans Trias i Pujol, para abordar la insuficiencia renal cr\u00f3nica y su relaci\u00f3n con el eje cardiometab\u00f3lico. <\/strong>Durante su exposici\u00f3n, afirm\u00f3 que \u201cla enfermedad renal cr\u00f3nica es la mayor epidemia cl\u00ednica que se acerca (despu\u00e9s del Alzheimer) y ya tenemos medios indudables que pueden disminuirla\u201d<\/strong>.<\/p>\n\n\n\n

\"Jordi<\/a>
Jordi Bover en un momento de su presentaci\u00f3n. <\/figcaption><\/figure>\n\n\n\n

El doctor tambi\u00e9n va definir y clasificar la enfermedad renal cr\u00f3nica<\/strong>, habl\u00f3 sobre la importancia de la alb\u00famina y la creatinina en la orina<\/strong>, e hizo referencia a la epidemiolog\u00eda y la prevalencia de esta patolog\u00eda<\/strong>, la nefro-cardioprotecci\u00f3n y el realismo-nihilismo terap\u00e9utico.<\/strong><\/p>\n\n\n\n

Insuficiencia card\u00edaca y su relaci\u00f3n con el eje renal metab\u00f3lico<\/strong><\/h2>\n\n\n\n

Por su parte, Antonio S\u00e1nchez, <\/strong>jefe de servicio de Cardiolog\u00eda del Consorcio Sanitario de Terrassa, expuso una situaci\u00f3n \u201ccada vez m\u00e1s frecuente\u201d<\/strong>, que es "la asociaci\u00f3n entre la enfermedad cardiovascular, la insuficiencia card\u00edaca y la obesidad"<\/strong>.Es decir, \u201csobre c\u00f3mo pasamos de una persona sana, activa y saludable a una persona con sobrepeso y exceso de tejido adiposo\u201d De este modo, el doctor indic\u00f3 que "a lo largo del tiempo acaba dando lugar a la presencia de factores de riesgo como la hipertensi\u00f3n, la diabetes o la enfermedad renal"<\/strong>. Y, posteriormente, \u201cse puede ver en pruebas diagn\u00f3sticas la afectaci\u00f3n de los \u00f3rganos diana como el coraz\u00f3n, el ri\u00f1\u00f3n, los vasos que terminan provocando enfermedades cardiovasculares como la insuficiencia card\u00edaca, entre otros\u201d<\/strong>.<\/p>\n\n\n\n

\"Antonio<\/a>
Antonio S\u00e1nchez impartiendo su sesi\u00f3n sobre la insuficiencia card\u00edaca y su relaci\u00f3n con el eje metab\u00f3lico. <\/figcaption><\/figure>\n\n\n\n

En este sentido, el Dr. S\u00e1nchez se centr\u00f3 en tres partes bien diferenciadas sobre la insuficiencia card\u00edaca<\/strong>: en primer lugar, especific\u00f3 cu\u00e1l es y su impacto en Catalu\u00f1a<\/strong>; en segundo lugar, abord\u00f3 eleje cardiometab\u00f3lico<\/strong>, es decir, \u201cen c\u00f3mo la obesidad afecta directamente al sistema cardiovascular\u201d; y, en tercer lugar, trat\u00f3 las medidas terap\u00e9uticas actuales y futuras.<\/p>\n\n\n\n

Diabetes mellitus y su relaci\u00f3n con el eje cardiorrenal<\/strong><\/h2>\n\n\n\n

En la segunda parte del curso, el Dr. Andreu Sim\u00f3<\/strong>, adjunto en el Servicio de Endocrinolog\u00eda y Nutrici\u00f3n del Hospital Mutua de Terrassa profundiz\u00f3 en la diabetes mellitus y su relaci\u00f3n con el eje cardiorenal<\/strong>. \u201cEl s\u00edndrome cardiorrenal es la interconexi\u00f3n entre el ri\u00f1\u00f3n, el coraz\u00f3n, la diabetes y la obesidad\u201d,<\/strong> describi\u00f3 Sim\u00f3n. Sobre este s\u00edndrome, el doctor destac\u00f3 que \u201ces importante tratarla antes de que aparezca el estadio final\u201d<\/strong>.<\/p>\n\n\n\n

\"Andreu<\/a>
Andreu Sim\u00f3 en un momento de su presentaci\u00f3n sobre la diabetes mellitus y su relaci\u00f3n con el eje cardiorrenal.<\/figcaption><\/figure>\n\n\n\n

A lo largo de su exposici\u00f3n, el doctor detall\u00f3 la patog\u00e9nesis<\/strong> de esta enfermedad desde el punto de vista del endocrino, los f\u00e1rmacos antihiperglucimiantes<\/strong>, los iSGLT2, y expuso cuatro casos cl\u00ednicos<\/strong> relacionados.  <\/p>\n\n\n\n

Por \u00faltimo, intervinieron la farmac\u00e9utica de atenci\u00f3n primaria de la Catalunya Central, Goizane Ros<\/strong>, y el m\u00e9dico de familia del EAP Vall del Ges, San Vicente de Torell\u00f3, Xavier Costa<\/strong>, para compartir con los asistentes diferentes casos cl\u00ednicos de pacientes cardiorenales metab\u00f3licos<\/strong>.<\/p>\n\n\n\n

\"Xavier<\/a>
Xavier Costa y Goizane Ros durante su exposici\u00f3n. <\/figcaption><\/figure>\n\n\n\n
\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Valoraci\u00f3n de Cristina Morales, vocal de Atenci\u00f3n Primaria del COFB<\/strong><\/h2>\n\n\n\n

La vocal de Atenci\u00f3n Primaria del COFB, Cristina<\/strong> Morales<\/strong>, valor\u00f3 positivamente el curso que se organiz\u00f3 con el prop\u00f3sito de ofrecer una visi\u00f3n multidisciplinar en el abordaje del paciente con riesgo cardiovascular<\/strong>. "Hemos cumplido con el prop\u00f3sito de la formaci\u00f3n dirigida a cada nivel asistencial con el que puede interactuar el paciente: la farmacia comunitaria, la hospitalaria y de atenci\u00f3n primaria", especific\u00f3 la vocal de Atenci\u00f3n Primaria del COFB.<\/p>\n\n\n\n

\"Cristina<\/a>
Cristina Morales presentando la formaci\u00f3n "Visi\u00f3n multidisciplinar del paciente cardiorenal metab\u00f3lico".<\/figcaption><\/figure>\n\n\n\n

Sin embargo, Morales asegur\u00f3 que el curso \u201cha generado mucho inter\u00e9s y despertado y sensibilizado sobre qu\u00e9 punto de mira debe tener cada perfil farmac\u00e9utico para acompa\u00f1ar al paciente con patolog\u00eda cr\u00f3nica y sobre c\u00f3mo seguir un correcto tratamiento\u201d<\/strong>.<\/p>\n\n\n\n

<\/p>\n\n\n\n<\/div>\n\n\n\n

\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Actividad organizada conjuntamente con:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Con el patrocinio de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

El pasado 25 de octubre, el Colegio de Farmac\u00e9uticos de Barcelona (COFB), con la colaboraci\u00f3n de la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC), organiz\u00f3 la formaci\u00f3n "Visi\u00f3n multidisciplinar del paciente cardiorenal metab\u00f3lico" con el patrocinio de Boehringer Ingelheim. La formaci\u00f3n, dirigida a farmac\u00e9uticos y farmac\u00e9uticas de atenci\u00f3n primaria y comunitarias, va [\u2026]<\/p>","protected":false},"author":3,"featured_media":79863,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[64,938,18,19,5159,5158,53,24,171,69,70,2744,2197,290,5157,523,286,129],"class_list":["post-79849","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-farmaceutica","tag-atencio-primaria","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-diabetis-mellitus","tag-eix-cardiorenal-metabolic","tag-farmaceutics","tag-farmaceutics-comunitaris","tag-farmaceutiques","tag-farmacia-comunitaria","tag-formacio","tag-insuficiencia-cardiaca","tag-insuficiencia-renal","tag-pacient","tag-pacient-cardiorenal-metabolic","tag-professionals-sanitaris","tag-societat-catalana-de-farmacia-clinica","tag-societat-catalana-de-farmacia-clinica-scfc"],"yoast_head":"\nVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic".\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/es\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic".\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/es\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-18T10:02:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T10:13:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries\",\"datePublished\":\"2024-11-18T10:02:47+00:00\",\"dateModified\":\"2024-11-18T10:13:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\"},\"wordCount\":1135,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"Atenci\u00f3 prim\u00e0ria\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"diabetis mellitus\",\"eix cardiorenal metab\u00f2lic\",\"farmac\u00e8utics\",\"farmac\u00e8utics comunitaris\",\"farmac\u00e8utiques\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"insufici\u00e8ncia card\u00edaca\",\"insufici\u00e8ncia renal\",\"pacient\",\"pacient cardiorenal metab\u00f2lic\",\"professionals sanitaris\",\"Societat Catalana de Farm\u00e0cia Cl\u00ednica\",\"Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\",\"url\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\",\"name\":\"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\",\"datePublished\":\"2024-11-18T10:02:47+00:00\",\"dateModified\":\"2024-11-18T10:13:09+00:00\",\"description\":\"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\\\".\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg\",\"width\":2560,\"height\":1440,\"caption\":\"Cristina Morales i Nuria Molist introduint la formaci\u00f3.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/es\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/es\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","og_locale":"es_ES","og_type":"article","og_title":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\".","og_url":"https:\/\/www.cofb.org\/es\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2024-11-18T10:02:47+00:00","article_modified_time":"2024-11-18T10:13:09+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"Berta Mart\u00ednez","Tiempo de lectura":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries","datePublished":"2024-11-18T10:02:47+00:00","dateModified":"2024-11-18T10:13:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/"},"wordCount":1135,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","keywords":["Atenci\u00f3 farmac\u00e8utica","Atenci\u00f3 prim\u00e0ria","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","diabetis mellitus","eix cardiorenal metab\u00f2lic","farmac\u00e8utics","farmac\u00e8utics comunitaris","farmac\u00e8utiques","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","insufici\u00e8ncia card\u00edaca","insufici\u00e8ncia renal","pacient","pacient cardiorenal metab\u00f2lic","professionals sanitaris","Societat Catalana de Farm\u00e0cia Cl\u00ednica","Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","url":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/","name":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","datePublished":"2024-11-18T10:02:47+00:00","dateModified":"2024-11-18T10:13:09+00:00","description":"El passat 25 d\u2019octubre, el COFB va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\".","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg","width":2560,"height":1440,"caption":"Cristina Morales i Nuria Molist introduint la formaci\u00f3."},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2024\/11\/18\/visio-multidisciplinaria-del-pacient-cardiorenal-metabolic-nou-curs-adrecat-a-farmaceutics-i-farmaceutiques-datencio-primaria-i-comunitaries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Visi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic, nou curs adre\u00e7at a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/11\/COFB_PACIENT-CARDIORENAL_14112024_1-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 25 d\u2019octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), amb la col\u00b7laboraci\u00f3 de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), va organitzar la formaci\u00f3 \u201cVisi\u00f3 multidisciplin\u00e0ria del pacient cardiorenal metab\u00f2lic\u201d amb el patrocini de Boehringer Ingelheim. La formaci\u00f3, adre\u00e7ada a farmac\u00e8utics i farmac\u00e8utiques d\u2019atenci\u00f3 prim\u00e0ria i comunit\u00e0ries, va […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/79849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=79849"}],"version-history":[{"count":33,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/79849\/revisions"}],"predecessor-version":[{"id":79891,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/79849\/revisions\/79891"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/79863"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=79849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=79849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=79849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}